Clinical Course and Outcomes of COVID-19 Infection in Patients Treated with Rituximab: A Tertiary Care Center Experience
Thamer S Alhowaish,1,2 Moustafa S Alhamadh,2,3 Alaa Mathkour,4 Marwan Alamoudi,2,5 Hossam Ali Alqahtani,1,2 Abdulrahman Alrashid2,3,5 1Division of Neurology, King Abdulaziz Medical City, Ministry of the National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia; 2King Abdullah International Medi...
Main Authors: | Alhowaish TS, Alhamadh MS, Mathkour A, Alamoudi M, Alqahtani HA, Alrashid A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-08-01
|
Series: | Open Access Rheumatology: Research and Reviews |
Subjects: | |
Online Access: | https://www.dovepress.com/clinical-course-and-outcomes-of-covid-19-infection-in-patients-treated-peer-reviewed-fulltext-article-OARRR |
Similar Items
-
Infection Risk, Mortality, and Hypogammaglobulinemia Prevalence and Associated Factors in Adults Treated with Rituximab: A Tertiary Care Center Experience
by: Moustafa S. Alhamadh, et al.
Published: (2023-10-01) -
Is Rituximab-Associated Hypogammaglobulinemia Always Linked to B-Cell Depletion?
by: Anthie Damianaki, et al.
Published: (2022-02-01) -
Rituximab in Kidney-Limited Microscopic Polyangiitis
by: Anvitha Madhavaram, et al.
Published: (2023-12-01) -
Rituximab and hypogammaglobulinemia in the setting of ABO-incompatible kidney transplantation
by: Hamza Naciri Bennani, et al.
Published: (2018-07-01) -
Staphylococcus Aureus carriage and long-term Rituximab treatment for Granulomatosis with polyangiitis
by: Emilio Besada, et al.
Published: (2015-06-01)